Evidence map›Paper›PMID 32762841›Full record

ArticleeLife2020

Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter

Ali H Alghamdi, Jane C Munday, Gustavo Daniel Campagnaro, Dominik Gurvic, Fredrik Svensson, Chinyere E Okpara, Arvind Kumar, Juan Quintana, Maria Esther Martin Abril, Patrik Milić and 25 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Functional Studies of Kinetoplastid Transporters.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Review
  4. Article
  5. Antitrypanosomal and Antileishmanial Activities ofMolecules (Basel, Switzerland) · 2025
    Article
  6. Cytological profiling of trypanocidal principles fromPhytomedicine plus : international journal of phytotherapy and phytopharmacology · 2025
    Article
  7. Article
  8. Review
  9. Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.International journal for parasitology. Drugs and drug resistance · 2024
    Review
  10. Article
  11. Synthesis and Biophysical and Biological Studies ofJournal of medicinal chemistry · 2023
    Article
  12. Review
  13. Cloning and Characterization ofInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Activity of Compounds from Temperate Propolis againstMolecules (Basel, Switzerland) · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 7 institutions in 4 countries.

Ali H AlghamdiInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Jane C MundayInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Gustavo Daniel CampagnaroInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0001-6542-0485
Dominik GurvicComputational Biology Centre for Translational and Interdisciplinary Research, University of Dundee, Dundee, United Kingdom.
Fredrik SvenssonIOTA Pharmaceuticals Ltd, St Johns Innovation Centre, Cambridge, United Kingdom.
Chinyere E OkparaDepartment of Chemistry, University of Liverpool, Liverpool, United Kingdom.
Arvind KumarChemistry Department, Georgia State University, Atlanta, United States.
Juan QuintanaSchool of Life Sciences, University of Dundee, Dundee, United Kingdom.
Maria Esther Martin AbrilInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Patrik MilićInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Laura WatsonInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Daniel PaapeInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Luca SettimoInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Anna DimitriouInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Joanna WielinskaInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Graeme SmartInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Laura F AndersonInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Christopher M WoodleyDepartment of Chemistry, University of Liverpool, Liverpool, United Kingdom.
Siu Pui Ying KellyInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Hasan Ms IbrahimInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Fabian HulpiaLaboratory for Medicinal Chemistry, University of Ghent, Ghent, Belgium.ORCID 0000-0002-7470-3484
Mohammed I Al-SalabiInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Anthonius A EzeInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0002-4821-1689
Teresa SprengerDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Ibrahim A TekaInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Simon GudinInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Simone WeyandDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.
Mark FieldSchool of Life Sciences, University of Dundee, Dundee, United Kingdom.
Christophe DardonvilleInstituto de Química Médica - CSIC, Madrid, Spain.
Richard R TidwellDepartment of Pathology and Lab Medicine, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Mark CarringtonDepartment of Biochemistry, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-6435-7266
Paul O'NeillDepartment of Chemistry, University of Liverpool, Liverpool, United Kingdom.
David W BoykinChemistry Department, Georgia State University, Atlanta, United States.
Ulrich ZachariaeComputational Biology Centre for Translational and Interdisciplinary Research, University of Dundee, Dundee, United Kingdom.
Harry P De KoningInstitute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.ORCID 0000-0002-9963-1827
University of Glasgow · GBUniversity of Dundee · GBUniversity of Cambridge · GBUniversity of Liverpool · GBGeorgia State University · USInstituto de Química Médica · ESUniversity of North Carolina at Chapel Hill · US

Funding

Molecular Design for Specific Recognition of Functional DNA SequencesR01GM111749 · NIGMS · GEORGIA STATE UNIVERSITY · PI WILSON, W DAVID · 2014 to 2021
$2.5M
Medical Research Council 84733Medical Research Council G0701258Medical Research Council MR/R015791/1NIGMS NIH HHS R01 GM111749NIH HHS GM111749Science Without Borders, Brazil 206385/2014-5Wellcome 204697/Z/16/ZWellcome Trust
6 · The paper itself

Abstract

Mutations in the

Indexed as

Aquaporin 2Trypanosoma brucei bruceiAnimalsAquaporinsDrug ResistanceMelarsoprolMutationPentamidineTrypanocidal AgentsTrypanosomiasis, AfricanAquaporin 2AquaporinsMelarsoprolPentamidineTrypanocidal Agentsaquaporinbiochemistrychemical biologydrug resistancedrug transportinfectious diseasemelarsoprolmicrobiologypentamidineTrypanosoma brucei

Identifiers

PMID32762841
PMCPMC7473772
OpenAlexW3047692861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.